TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 23266603

Group type: EXPERIMENTAL
Intervention: Visual search attentional bias modification (ABM) training
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control training
Number of subjects: 40
Study: 21723567

Group type: EXPERIMENTAL
Intervention: 1,25(OH)(2) Vitamin D
Number of subjects: 132
Study: 18327986

Group type: EXPERIMENTAL
Intervention: darunavir/r (600/100 mg bid)
Number of subjects: 458
Study: 16801663

Group type: EXPERIMENTAL
Intervention: Haplotypes ‐2578‐A/‐1154‐A/‐634‐G or ‐2578‐A/‐1154‐G/‐634‐G in the VEGF gene
Number of subjects: 580

Group type: EXPERIMENTAL
Intervention: Promoter SNP‐1154 (rs1570360)
Number of subjects: 580

Group type: COMPARATOR
Intervention: Control group (628 individuals)
Number of subjects: 580
Study: 14733474

Group type: EXPERIMENTAL
Intervention: Esthetic crowns
Number of subjects: 10

Group type: COMPARATOR
Intervention: Stainless steel crowns (SSC)
Number of subjects: 10
Study: 10946892

Group type: EXPERIMENTAL
Intervention: 1% T gel (50 or 100 mg/day)
Number of subjects: 227

Group type: EXPERIMENTAL
Intervention: 1% T gel (100 mg/day)
Number of subjects: 227

Group type: EXPERIMENTAL
Intervention: 1% T gel (50 mg/day)
Number of subjects: 227

Group type: COMPARATOR
Intervention: T patch (5 mg/day)
Number of subjects: 227

Group type: EXPERIMENTAL
Intervention: 1% T gel
Number of subjects: 227

Group type: COMPARATOR
Intervention: T patch
Number of subjects: 227
Study: 9005385

Group type: EXPERIMENTAL
Intervention: Cyproterone acetate
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Dexamethasone
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Spironolactone
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Clomiphene and gonadotrophin (pure FSH)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 24
Study: 1457767

Group type: EXPERIMENTAL
Intervention: Captopril (25 mg three times daily)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 6749206

Group type: EXPERIMENTAL
Intervention: Conventional high-dose prednisone
Number of subjects: 62

Group type: COMPARATOR
Intervention: Cytotoxic drugs
Number of subjects: 62
Study: 29369458

Group type: EXPERIMENTAL
Intervention: Celeriac cultivar 'Anita'
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Celeriac cultivar 'Prinz'
Number of subjects: 16
Study: 27055799

Group type: EXPERIMENTAL
Intervention: Self‐made single‐tube double lumen 'H shaped' drainage tube (Group A)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Traditional silicone drainage tube (Group B)
Number of subjects: 56
Study: 25666998

Group type: EXPERIMENTAL
Intervention: Intravenous iron sucrose (200mg/mL weekly for five weeks)
Number of subjects: 60
Study: 23085502

Group type: EXPERIMENTAL
Intervention: Occupational therapy home program (OTHP) for 20 weeks, average 15 min per session
Number of subjects: 0

Group type: COMPARATOR
Intervention: No OTHP
Number of subjects: 0
Study: 21095115

Group type: EXPERIMENTAL
Intervention: CNS-directed therapy with intravenous methotrexate (5 g/sqm) in 4-10 courses and intrathecal methotrexate injections (10-20), no cranial irradiation.
Number of subjects: 2025
Study: 19011778

Group type: EXPERIMENTAL
Intervention: Low-molecular-weight hydroxyethyl starch (HES) at 2 ml x kg(‐1) x h(‐1) during surgery and 1 ml x kg(‐1) x h(‐1) after surgery, plus acetated Ringer's solution (AR) to maintain CVP at 5 mm Hg
Number of subjects: 21

Group type: COMPARATOR
Intervention: Acetated Ringer's solution (AR) to maintain CVP at 3-5 mmHg
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Low-molecular-weight hydroxyethyl starch (HES)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Acetated Ringer's solution (AR)
Number of subjects: 21
Study: 16980114

Group type: EXPERIMENTAL
Intervention: Inactivated whole-virion influenza A (H5N1) vaccine with 1.25 microg (24), 2.5 microg (24), 5 microg (24), or 10 microg (24) haemagglutinin per dose with aluminium hydroxide adjuvant
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo (n=24)
Number of subjects: 120
Study: 15554283

Group type: EXPERIMENTAL
Intervention: Alpha port/laparoscope image
Number of subjects: 14
Study: 10676669

Group type: EXPERIMENTAL
Intervention: L-arginine 9 g daily for one month
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 9424647

Group type: EXPERIMENTAL
Intervention: Percutaneous ethanol injection (PEI)
Number of subjects: 290

Group type: EXPERIMENTAL
Intervention: Chemoembolization (CEAT)
Number of subjects: 290

Group type: EXPERIMENTAL
Intervention: PEI
Number of subjects: 290

Group type: EXPERIMENTAL
Intervention: CEAT
Number of subjects: 290

Group type: COMPARATOR
Intervention: No treatment (NT)
Number of subjects: 290
Study: 8457093

Group type: EXPERIMENTAL
Intervention: Mechanical CPR
Number of subjects: 15

Group type: COMPARATOR
Intervention: Manual CPR
Number of subjects: 15
Study: 3522474

Group type: EXPERIMENTAL
Intervention: Ranitidine
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study: 29143193

Group type: EXPERIMENTAL
Intervention: Cigarette Purchase Task (CPT) for depressed smokers
Number of subjects: 165

Group type: COMPARATOR
Intervention: Cigarette Purchase Task (CPT) for non-depressed smokers
Number of subjects: 165
Study: 26331581

Group type: EXPERIMENTAL
Intervention: Apixaban (5 mg single oral dose administered twice to subjects with ESRD, once before hemodialysis and once after hemodialysis)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Apixaban (5 mg single oral dose administered before and after hemodialysis)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Healthy subjects (control group)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Apixaban (5 mg single oral dose)
Number of subjects: 16
Study: 23728476

Group type: EXPERIMENTAL
Intervention: Progressive training program (virtual reality, task trainer, and mannequin simulator)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: High-fidelity program (mannequin)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Low-fidelity program (virtual reality)
Number of subjects: 45
Study: 21473794

Group type: EXPERIMENTAL
Intervention: Autologous cumulus cell embryo co-culture and transfer at day 5-6
Number of subjects: 432

Group type: COMPARATOR
Intervention: Classical culture and day 3 transfer
Number of subjects: 432
Study: 21626819

Group type: EXPERIMENTAL
Intervention: Axamon (20 mg 3 times a day for 12 weeks)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Basic therapy
Number of subjects: 50
Study: 18633022

Group type: EXPERIMENTAL
Intervention: Palonosetron 0.075 mg
Number of subjects: 574

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 574
Study: 15896281

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy (CBT) plus continued psychopharmacology
Number of subjects: 31

Group type: COMPARATOR
Intervention: Continued psychopharmacology alone
Number of subjects: 31
Study: 11735172

Group type: EXPERIMENTAL
Intervention: levamisole/UFT chemotherapy (N=29)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Control group (N=34)
Number of subjects: 65
Study: 9440632

Group type: EXPERIMENTAL
Intervention: 15 mg/day lansoprazole
Number of subjects: 186

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 186
Study: 8306000

Group type: EXPERIMENTAL
Intervention: MEDLINE search strategy
Number of subjects: 5583

Group type: EXPERIMENTAL
Intervention: Combination of MEDLINE and selective hand search
Number of subjects: 5583

Group type: COMPARATOR
Intervention: Hand search of entire journals
Number of subjects: 5583

Group type: COMPARATOR
Intervention: MEDLINE search
Number of subjects: 5583
Study: 3597149

Group type: EXPERIMENTAL
Intervention: Radiation therapy and misonidazole (1.5 gm/m2 daily 4‐6 hr before each treatment)
Number of subjects: 214

Group type: COMPARATOR
Intervention: Radiation therapy alone
Number of subjects: 214

Group type: EXPERIMENTAL
Intervention: Radiation therapy and misonidazole
Number of subjects: 214
Study: 30092666

Group type: EXPERIMENTAL
Intervention: 0.5 μg/kg dexmedetomidine via intravenous pump
Number of subjects: 31
Study: 26040282

Group type: EXPERIMENTAL
Intervention: Distraction cards
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Listening to the music of cartoon
Number of subjects: 120
Study: 23635803

Group type: EXPERIMENTAL
Intervention: Disulfiram (250 mg/day)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 68
Study: 21628421

Group type: EXPERIMENTAL
Intervention: Glucose data-filtering system with automatic response software
Number of subjects: 79

Group type: COMPARATOR
Intervention: Control group (manual contact by physicians)
Number of subjects: 79
Study: 18692841

Group type: EXPERIMENTAL
Intervention: Low-dose aspirin (LDA) 100 mg daily
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Omega-3 fatty acids 4 g daily
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: LDA plus Omega-3
Number of subjects: 60
Study: 17229604

Group type: COMPARATOR
Intervention: Ablation alone (Group A)
Number of subjects: 255

Group type: EXPERIMENTAL
Intervention: Imiquimod 5% cream monotherapy (Group B)
Number of subjects: 255

Group type: EXPERIMENTAL
Intervention: Combined ablation followed by topical imiquimod (Group C)
Number of subjects: 255
Study: 12547874

Group type: EXPERIMENTAL
Intervention: Atorvastatin 10 mg (A10)
Number of subjects: 198

Group type: EXPERIMENTAL
Intervention: Atorvastatin 80 mg (A80)
Number of subjects: 198

Group type: COMPARATOR
Intervention: Control group (placebo)
Number of subjects: 198
Study: 10979057

Group type: EXPERIMENTAL
Intervention: Warfarin alone (INR maintained at 1.4 or more)
Number of subjects: 2545

Group type: COMPARATOR
Intervention: Warfarin and aspirin (75 mg/d)
Number of subjects: 2545
Study: 9024712

Group type: EXPERIMENTAL
Intervention: NFL (Mitoxantrone, 5-fluorouracil, high dose leucovorin)
Number of subjects: 128

Group type: COMPARATOR
Intervention: CMF (Cyclophosphamide, Methotrexate, 5-fluorouracil)
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: NFL
Number of subjects: 128

Group type: COMPARATOR
Intervention: CMF
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: NFL and CMF
Number of subjects: 128
Study: 8336248

Group type: EXPERIMENTAL
Intervention: Chlorhexidine dentifrice applied undiluted via toothshield
Number of subjects: 88

Group type: COMPARATOR
Intervention: Placebo dentifrice applied undiluted via toothshield
Number of subjects: 88
Study: 3595067

Group type: EXPERIMENTAL
Intervention: 20 mg isosorbide‐5‐mononitrate (IS‐5MN)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 40 mg isosorbide‐5‐mononitrate (IS‐5MN)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 29335018

Group type: EXPERIMENTAL
Intervention: Danggwijagyaksan (DJS)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34
Study: 27845765

Group type: EXPERIMENTAL
Intervention: Intranasal Oxytocin (OT) administration
Number of subjects: 0
Study: 25636895

Group type: EXPERIMENTAL
Intervention: Self-inflating bag (SIB)
Number of subjects: 90

Group type: COMPARATOR
Intervention: T-piece resuscitator (TPR)
Number of subjects: 90

Group type: COMPARATOR
Intervention: T-piece resuscitator (TPR) in neonates <34 weeks
Number of subjects: 90
Study: 22935722

Group type: EXPERIMENTAL
Intervention: Belief in having a gene associated with alcoholism
Number of subjects: 0
Study: 20493557

Group type: EXPERIMENTAL
Intervention: Pregnenolone (titrated to 100mg/day)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70
Study: 18463376

Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 751

Group type: COMPARATOR
Intervention: Insulin
Number of subjects: 751
Study: 22207098

Group type: EXPERIMENTAL
Intervention: Daily care activities (washing, dressing, transfer)
Number of subjects: 40
Study: 16138670

Group type: EXPERIMENTAL
Intervention: Botulinum toxin A (BTX‐A) only
Number of subjects: 39

Group type: COMPARATOR
Intervention: Placebo injection plus casting
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Botulinum toxin A plus casting (BTX‐A + casting)
Number of subjects: 39
Study: 11806988

Group type: EXPERIMENTAL
Intervention: 7-day prednisone (PDN) pretreatment
Number of subjects: 778

Group type: EXPERIMENTAL
Intervention: Conventional 4-drug induction with cyclophosphamide
Number of subjects: 778

Group type: EXPERIMENTAL
Intervention: Induction intensification (8-drug consolidation)
Number of subjects: 778

Group type: COMPARATOR
Intervention: Maintenance alone
Number of subjects: 778

Group type: COMPARATOR
Intervention: Consolidation followed by maintenance
Number of subjects: 778

Group type: EXPERIMENTAL
Intervention: Overall survival (OS)
Number of subjects: 778

Group type: EXPERIMENTAL
Intervention: Continuous complete remission (CCR)
Number of subjects: 778

Group type: EXPERIMENTAL
Intervention: Disease-free survival (DFS)
Number of subjects: 778
Study: 9453332

Group type: EXPERIMENTAL
Intervention: Losartan (100 mg daily)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study: 7993860

Group type: EXPERIMENTAL
Intervention: Laparoscopic cholecystectomy (LC)
Number of subjects: 1548

Group type: COMPARATOR
Intervention: Conventional cholecystectomy (CC)
Number of subjects: 1548
Study: 3224162

Group type: EXPERIMENTAL
Intervention: 20 mg oral propranolol every 6 hours (test dosage form)
Number of subjects: 28
Study: 30124439

Group type: EXPERIMENTAL
Intervention: Ultrasound
Number of subjects: 78

Group type: COMPARATOR
Intervention: Thermography
Number of subjects: 78
Study: 26754586

Group type: EXPERIMENTAL
Intervention: 2 mg pitavastatin daily + intensive lifestyle modification (LSM)
Number of subjects: 75

Group type: COMPARATOR
Intervention: intensive lifestyle modification (LSM) only
Number of subjects: 75
Study: 25762232

Group type: EXPERIMENTAL
Intervention: Daptomycin 10 mg/kg/24 h intravenous plus fosfomycin 2 gr/6 g intravenous
Number of subjects: 103

Group type: COMPARATOR
Intervention: Daptomycin 10 mg/kg/24 h intravenous
Number of subjects: 103
Study: 22951572

Group type: EXPERIMENTAL
Intervention: RTW-E (exposure-based return-to-work intervention)
Number of subjects: 160

Group type: COMPARATOR
Intervention: CAU (care-as-usual)
Number of subjects: 160
Study: 19926385

Group type: EXPERIMENTAL
Intervention: Simulation
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: Multimedia
Number of subjects: 117

Group type: COMPARATOR
Intervention: Reading
Number of subjects: 117
Study: 18806109

Group type: EXPERIMENTAL
Intervention: Zinc supplementation (10 mg/d) for 6 months
Number of subjects: 2451

Group type: EXPERIMENTAL
Intervention: Iron supplementation (10 mg/d) for 6 months
Number of subjects: 2451

Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 2451
Study: 16463145

Group type: EXPERIMENTAL
Intervention: Ureteroscopic management using holmium laser fragmentation with a 200 microm holmium laser fiber via a 7.5 F flexible ureteroscope.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nitinol basket or grasper retrieval for stone displacement.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Shockwave lithotripsy (SWL)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Percutaneous nephrolithotomy (PNL)
Number of subjects: 0
Study: 12542723

Group type: EXPERIMENTAL
Intervention: acarbose 100 mg t.i.d.
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: glibenclamide 1 mg t.i.d.
Number of subjects: 77

Group type: COMPARATOR
Intervention: placebo t.i.d.
Number of subjects: 77
Study: 11099583

Group type: EXPERIMENTAL
Intervention: Baby CareLink telemedicine application
Number of subjects: 56

Group type: COMPARATOR
Intervention: Control group (usual care)
Number of subjects: 56
Study: 9014669

Group type: EXPERIMENTAL
Intervention: General prophylaxis with unfractionated heparin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: General prophylaxis with low molecular weight heparin (LMWH)
Number of subjects: 0

Group type: COMPARATOR
Intervention: No prophylaxis against DVT
Number of subjects: 0

Group type: COMPARATOR
Intervention: Selective treatment of DVT after confirmation of diagnosis
Number of subjects: 0
Study: 1642678

Group type: EXPERIMENTAL
Intervention: Single administration of clentiazem (30 mg)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Repeated administration of clentiazem (30 mg daily for 2 weeks)
Number of subjects: 27
Study: 6650976

Group type: EXPERIMENTAL
Intervention: Normal saline (pH 5.5) at room temperature (25 degrees C)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Normal saline at 37 degrees C in RML, normal saline buffered to pH 7.0 at 37 degrees C in RLL, normal saline at 25 degrees C in left lingula, normal saline buffered to pH 7.0 at 25 degrees C in LLL
Number of subjects: 0
Study: 29609594

Group type: EXPERIMENTAL
Intervention: Physical Activity Intervention
Number of subjects: 307

Group type: COMPARATOR
Intervention: Healthy Aging Attention Control
Number of subjects: 307
Study: 26976553

Group type: EXPERIMENTAL
Intervention: Composite resin restorations
Number of subjects: 47

Group type: COMPARATOR
Intervention: Metal-ceramic crowns
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Overall
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Comparison of restoration types
Number of subjects: 47
Study: 24908970

Group type: EXPERIMENTAL
Intervention: High-dose tamoxifen therapy in combination with chemotherapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Chemotherapy only
Number of subjects: 0
Study: 23770971

Group type: EXPERIMENTAL
Intervention: SRT2104 (2.0 g/day)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 20837462

Group type: EXPERIMENTAL
Intervention: Pemetrexed 500 mg/m2 plus carboplatin AUC 6 for 4 cycles followed by maintenance pemetrexed
Number of subjects: 360

Group type: COMPARATOR
Intervention: Paclitaxel 200 mg/m2 plus carboplatin AUC 6 plus bevacizumab 15 mg/kg for 4 cycles followed by maintenance bevacizumab
Number of subjects: 360
Study: 18346712

Group type: EXPERIMENTAL
Intervention: Exposure writing
Number of subjects: 198

Group type: EXPERIMENTAL
Intervention: Benefit-finding writing
Number of subjects: 198

Group type: COMPARATOR
Intervention: Unstructured emotion writing
Number of subjects: 198
Study: 16883902

Group type: EXPERIMENTAL
Intervention: Tiepi Fengdou Granule (TFG)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Tiepi Fengdou Capsule (TFC)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Shengmai Capsule (Control)
Number of subjects: 80
Study: 15379415

Group type: EXPERIMENTAL
Intervention: Combined, structured multidisciplinary weight management program (dietary-behavioral-exercise intervention) for 12 months
Number of subjects: 77

Group type: COMPARATOR
Intervention: Control group (obese children who did not participate in the structured program)
Number of subjects: 77
Study: 11762816

Group type: EXPERIMENTAL
Intervention: Intravenous pamidronate 90 mg monthly
Number of subjects: 51

Group type: COMPARATOR
Intervention: Oral clodronate 1,600 mg daily
Number of subjects: 51

Group type: COMPARATOR
Intervention: Intravenous clodronate followed by oral clodronate
Number of subjects: 51
Study: 9260018

Group type: EXPERIMENTAL
Intervention: Rocuronium (Group R)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Pancuronium (Group P)
Number of subjects: 20
Study: 8315645

Group type: EXPERIMENTAL
Intervention: Stress cues
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: Stress cues with heart attack symptoms
Number of subjects: 83

Group type: COMPARATOR
Intervention: Age manipulation
Number of subjects: 83
Study: 3565931

Group type: EXPERIMENTAL
Intervention: Exercise-induced asthma (EIA)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Hypertonic 3.6% saline challenge
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Hypertonic challenge
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Exercise
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Histamine-induced bronchoconstriction
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Inhalation of isotonic saline
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Exercise and aerosolized hypertonic saline
Number of subjects: 10
Study: 31567160

Group type: EXPERIMENTAL
Intervention: Immediate switch to TDF/FTC/rilpivirine (RPV)
Number of subjects: 74

Group type: COMPARATOR
Intervention: Delayed switch to TDF/FTC/rilpivirine (RPV)
Number of subjects: 74
Study: 29397258

Group type: EXPERIMENTAL
Intervention: Propofol-fentanyl (PF)
Number of subjects: 136

Group type: COMPARATOR
Intervention: Propofol-ketamine (PK)
Number of subjects: 136
Study: 27908846

Group type: EXPERIMENTAL
Intervention: My Asthma Portal (MAP)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 100
Study: 24259556

Group type: EXPERIMENTAL
Intervention: Zinc citrate (10 mg)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Zinc gluconate (10 mg)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Zinc oxide (10 mg)
Number of subjects: 15
Study: 23202814

Group type: EXPERIMENTAL
Intervention: Methods video (focused on intrauterine device and contraceptive implant)
Number of subjects: 1060

Group type: COMPARATOR
Intervention: Motivational videos
Number of subjects: 1060

Group type: EXPERIMENTAL
Intervention: Methods video (in concordant positive couples)
Number of subjects: 1060

Group type: EXPERIMENTAL
Intervention: Methods video (in couples with HIV-positive women)
Number of subjects: 1060
Study: 20861399

Group type: EXPERIMENTAL
Intervention: Aerobic exercise training (AET)
Number of subjects: 242

Group type: EXPERIMENTAL
Intervention: Resistance exercise training (RET)
Number of subjects: 242

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 242
Study: 17664051

Group type: EXPERIMENTAL
Intervention: Naltrexone 150 mg/day for 12 weeks
Number of subjects: 164

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 164
Study: 16636114

Group type: EXPERIMENTAL
Intervention: ECMO treatment
Number of subjects: 100

Group type: COMPARATOR
Intervention: Conventional management
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 100
Study: 12796578

Group type: EXPERIMENTAL
Intervention: 8-mm prosthetic H-graft portacaval shunt (HGPCS)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Transjugular intrahepatic portosystemic shunt (TIPS)
Number of subjects: 62